Tuesday
07.16.2019
5:44 AM
Login form
Search
Calendar
«  December 2013  »
SuMoTuWeThFrSa
1234567
891011121314
15161718192021
22232425262728
293031
Entries archive

Africa Live News

Main » 2013 » December » 22 » First-in-Man Implantation of CARMAT’s Bioprosthetic Artificial Heart
5:34 PM
First-in-Man Implantation of CARMAT’s Bioprosthetic Artificial Heart
PARIS. - Saturday, December 21st 2013 [ME NewsWire]

(BUSINESS WIRE) CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart project, providing an alternative for people suffering from end-stage heart failure, announces the first implantation of its artificial heart, as part of its feasibility study and in accordance with the approvals granted by the ANSM (Agence nationale de  sécurité du médicament et des produits de santé, the French health authority) and the Comité de Protection des Personnes (ethics committee).

The procedure was performed on December 18, 2013 by the Georges Pompidou European Hospital team in Paris (France) - a world first.

This first implant went smoothly, with the prosthesis automatically providing normal blood flow at a physiological rate. The patient is currently being monitored in intensive care. He is awake and able to talk to his family.

"We are delighted with this first implant, although it is obviously far too early to draw conclusions given that this is the first such implant and surgery has only just been performed”, says Marcello Conviti, Chief Executive Officer of CARMAT.

About CARMAT: the world’s most advanced total artificial heart project.

The only credible response for all cases of end-stage heart failure, which is a real public health issue: CARMAT’s aim is to be able to provide a response to a major public health issue associated with heart disease, the world’s leading cause of death: chronic and acute heart failure. Indeed, this disease currently affects over 100 million patients in developed countries. By pursuing the development of its total artificial heart, CARMAT intends to overcome the well-known shortfall in heart transplants for the tens of thousands of people suffering from heart failure.

For more information: www.carmatsa.com

Contacts

CARMAT

Marcello Conviti - CEO

Patrick Coulombier - COO

Valerie Leroy - Director of Marketing & Investor Relations

Tel. : +33 139 456450

contact@carmatsas.com

 

Alize RP

Press relations

Caroline Carmagnol

Christian Berg

+33 170 225386

caroline@alizerp.com

christian@alizerp.com

 

NewCap

Financial communication and investor relations

Dušan Orešanský / Emmanuel Huynh

Tel.: +33 144 719494

carmat@newcap.fr

 

 

Views: 90 | Added by: uaeonlinenews | Rating: 0.0/0
Total comments: 0
Name *:
Email *:
Code *: